Advertisement

Topics

BioLineRx plans phase III BL-8040 registrational study of stem cell mobilization

10:23 EDT 22 Aug 2017 | CentreWatch

BioLineRx, a clinical-stage biopharmaceutical company focused on oncology and immunology, announced the filing of regulatory submissions required to commence a randomized, controlled phase III registrational trial of BL-8040 for the mobilization of hematopoietic stem cells for autologous transplantation in patients with multiple myeloma. The trial, named GENESIS, is expected to commence by the end of […]

The post BioLineRx plans phase III BL-8040 registrational study of stem cell mobilization appeared first on CenterWatch News Online.

Original Article: BioLineRx plans phase III BL-8040 registrational study of stem cell mobilization

NEXT ARTICLE

More From BioPortfolio on "BioLineRx plans phase III BL-8040 registrational study of stem cell mobilization"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Immunology
Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...